CONNECT WITH US
HealthTech

HealthTech

Humana enters $2.8B primary care joint venture with BlackRock

Healthcare Dive logo

Published on

Add as a preferred source on Google
Humana enters $2.8B primary care joint venture with BlackRock

Investment firm BlackRock will acquire a majority stake in nearly 150 CenterWell Senior Primary Care care clinics, Humana announced Tuesday.

Humana has been doubling down on primary care delivery in a bid to diversify its revenue in recent years, expanding CenterWell through a series of investments and acquisitions. The division has grown to operate more than 350 senior primary care locations through CenterWell Senior Primary Care and its sister brand, Conviva Senior Primary Care.

Now, over the next two years, BlackRock, one of the biggest investment firms in the world, will use its deep pockets to fuel CenterWell’s growth, including by building clinics and pursuing new acquisitions, Humana said.

Under the deal announced Tuesday, BlackRock will hold a majority stake in nearly 150 CenterWell clinics previously backed by WCAS.

The joint ventures with WCAS, established in 2020 and 2022, “were instrumental in successfully scaling CenterWell into the nation’s largest provider of senior-focused value-based primary care over the last seven years,” Humana said in a statement.

But the new joint venture with BlackRock offers greater financial and operational flexibility for Humana.

Humana says it expects a significant reduction in the liabilities on its balance sheet due to the removal of a “put option” in the new joint venture. A put option would essentially force Humana to buy back their equity stake in the clinics at a predetermined price, regardless of whether Humana wanted to make that purchase at that time. WCAS had a put option as part of its deal, but that clause has been removed for BlackRock.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.